Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial

Published:2001-06 Issue:9274 Volume:357 Page:2085-2089
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Neumann Franz-Josef,Kastrati Adnan,Miethke Thomas,Pogatsa-Murray Gisela,Mehilli Julinda,Valina Christian,Jogethaei Nader,da Costa Clarissa P,Wagner Hermann,Schömig Albert

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Atherosclerosis—an inflammatory disease;Ross;N Engl J Med,1999

2. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease;Thom;JAMA,1992

3. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease;Linnanmaki;Circulation,1993

4. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction;Gupta;Circulation,1997

5. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease;Maass;J Am Coll Cardiol,1998

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semiparametric single-index models for optimal treatment regimens with censored outcomes;Lifetime Data Analysis;2022-08-08

2. Antibiotics for secondary prevention of coronary heart disease;Cochrane Database of Systematic Reviews;2021-02-23

3. Adverse events in people taking macrolide antibiotics versus placebo for any indication;Cochrane Database of Systematic Reviews;2019-01-18

4. Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides;Antimicrobial Agents and Chemotherapy;2018-06

5. Long-Term Risk of Cardiovascular Death With Use of Clarithromycin and Roxithromycin: A Nationwide Cohort Study;American Journal of Epidemiology;2017-11-16